Copyright Reports & Markets. All rights reserved.

Global TB Vaccines Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 TB Vaccines Market Overview

      • 1.1 Product Overview and Scope of TB Vaccines
      • 1.2 TB Vaccines Segment by Type
        • 1.2.1 Global TB Vaccines Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Mobile
        • 1.2.3 Benchtop
      • 1.3 TB Vaccines Segment by Application
        • 1.3.1 TB Vaccines Consumption Comparison by Application (2014-2025)
        • 1.3.2 For Water Analysis
        • 1.3.3 Measuring
        • 1.3.4 Laboratory
        • 1.3.5 Others
      • 1.4 Global TB Vaccines Market by Region
        • 1.4.1 Global TB Vaccines Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global TB Vaccines Market Size
        • 1.5.1 Global TB Vaccines Revenue (2014-2025)
        • 1.5.2 Global TB Vaccines Production (2014-2025)

      2 Global TB Vaccines Market Competition by Manufacturers

      • 2.1 Global TB Vaccines Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global TB Vaccines Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global TB Vaccines Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers TB Vaccines Production Sites, Area Served, Product Types
      • 2.5 TB Vaccines Market Competitive Situation and Trends
        • 2.5.1 TB Vaccines Market Concentration Rate
        • 2.5.2 TB Vaccines Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global TB Vaccines Production Market Share by Regions

      • 3.1 Global TB Vaccines Production Market Share by Regions
      • 3.2 Global TB Vaccines Revenue Market Share by Regions (2014-2019)
      • 3.3 Global TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America TB Vaccines Production
        • 3.4.1 North America TB Vaccines Production Growth Rate (2014-2019)
        • 3.4.2 North America TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe TB Vaccines Production
        • 3.5.1 Europe TB Vaccines Production Growth Rate (2014-2019)
        • 3.5.2 Europe TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China TB Vaccines Production (2014-2019)
        • 3.6.1 China TB Vaccines Production Growth Rate (2014-2019)
        • 3.6.2 China TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan TB Vaccines Production (2014-2019)
        • 3.7.1 Japan TB Vaccines Production Growth Rate (2014-2019)
        • 3.7.2 Japan TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global TB Vaccines Consumption by Regions

      • 4.1 Global TB Vaccines Consumption by Regions
      • 4.2 North America TB Vaccines Consumption (2014-2019)
      • 4.3 Europe TB Vaccines Consumption (2014-2019)
      • 4.4 China TB Vaccines Consumption (2014-2019)
      • 4.5 Japan TB Vaccines Consumption (2014-2019)

      5 Global TB Vaccines Production, Revenue, Price Trend by Type

      • 5.1 Global TB Vaccines Production Market Share by Type (2014-2019)
      • 5.2 Global TB Vaccines Revenue Market Share by Type (2014-2019)
      • 5.3 Global TB Vaccines Price by Type (2014-2019)
      • 5.4 Global TB Vaccines Production Growth by Type (2014-2019)

      6 Global TB Vaccines Market Analysis by Applications

      • 6.1 Global TB Vaccines Consumption Market Share by Application (2014-2019)
      • 6.2 Global TB Vaccines Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in TB Vaccines Business

      • 7.1 Merck & Co.,Inc
        • 7.1.1 Merck & Co.,Inc TB Vaccines Production Sites and Area Served
        • 7.1.2 TB Vaccines Product Introduction, Application and Specification
        • 7.1.3 Merck & Co.,Inc TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Sanofi Pasteur
        • 7.2.1 Sanofi Pasteur TB Vaccines Production Sites and Area Served
        • 7.2.2 TB Vaccines Product Introduction, Application and Specification
        • 7.2.3 Sanofi Pasteur TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Japan BCG Laboratory
        • 7.3.1 Japan BCG Laboratory TB Vaccines Production Sites and Area Served
        • 7.3.2 TB Vaccines Product Introduction, Application and Specification
        • 7.3.3 Japan BCG Laboratory TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 China National Biotec Group
        • 7.4.1 China National Biotec Group TB Vaccines Production Sites and Area Served
        • 7.4.2 TB Vaccines Product Introduction, Application and Specification
        • 7.4.3 China National Biotec Group TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Serum Institute
        • 7.5.1 Serum Institute TB Vaccines Production Sites and Area Served
        • 7.5.2 TB Vaccines Product Introduction, Application and Specification
        • 7.5.3 Serum Institute TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 India Pvt. Ltd
        • 7.6.1 India Pvt. Ltd TB Vaccines Production Sites and Area Served
        • 7.6.2 TB Vaccines Product Introduction, Application and Specification
        • 7.6.3 India Pvt. Ltd TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 InterVax Ltd
        • 7.7.1 InterVax Ltd TB Vaccines Production Sites and Area Served
        • 7.7.2 TB Vaccines Product Introduction, Application and Specification
        • 7.7.3 InterVax Ltd TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 GreenSignal
        • 7.8.1 GreenSignal TB Vaccines Production Sites and Area Served
        • 7.8.2 TB Vaccines Product Introduction, Application and Specification
        • 7.8.3 GreenSignal TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Bio Pharma Limited
        • 7.9.1 Bio Pharma Limited TB Vaccines Production Sites and Area Served
        • 7.9.2 TB Vaccines Product Introduction, Application and Specification
        • 7.9.3 Bio Pharma Limited TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Statens Serum Institut
        • 7.10.1 Statens Serum Institut TB Vaccines Production Sites and Area Served
        • 7.10.2 TB Vaccines Product Introduction, Application and Specification
        • 7.10.3 Statens Serum Institut TB Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 TB Vaccines Manufacturing Cost Analysis

      • 8.1 TB Vaccines Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of TB Vaccines
      • 8.4 TB Vaccines Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 TB Vaccines Distributors List
      • 9.3 TB Vaccines Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global TB Vaccines Market Forecast

      • 11.1 Global TB Vaccines Production, Revenue Forecast
        • 11.1.1 Global TB Vaccines Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global TB Vaccines Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global TB Vaccines Price and Trend Forecast (2019-2025)
      • 11.2 Global TB Vaccines Production Forecast by Regions (2019-2025)
        • 11.2.1 North America TB Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe TB Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.3 China TB Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan TB Vaccines Production, Revenue Forecast (2019-2025)
      • 11.3 Global TB Vaccines Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America TB Vaccines Consumption Forecast (2019-2025)
        • 11.3.2 Europe TB Vaccines Consumption Forecast (2019-2025)
        • 11.3.3 China TB Vaccines Consumption Forecast (2019-2025)
        • 11.3.4 Japan TB Vaccines Consumption Forecast (2019-2025)
      • 11.4 Global TB Vaccines Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global TB Vaccines Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.

        The global TB Vaccines market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on TB Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall TB Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Merck & Co.,Inc
        Sanofi Pasteur
        Japan BCG Laboratory
        China National Biotec Group
        Serum Institute
        India Pvt. Ltd
        InterVax Ltd
        GreenSignal
        Bio Pharma Limited
        Statens Serum Institut

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Mobile
        Benchtop

        Segment by Application
        For Water Analysis
        Measuring
        Laboratory
        Others

        Buy now